PowerTrials and PowerTrials Screener

PowerTrials is the research module that resides within the Electronic Health Record at Augusta University Medical Center (AUMC) and the Children's Hospital of Georgia. PowerChart is the name of the electronic health record.

Research Development Services (RDS) is responsible for administering PowerTrials. Each study that utilizes a billable hospital service is entered in OnCore. The research site is responsible for entering each patient that becomes enrolled in the study into OnCore. The RDS PowerTrials Administrator provides training to support investigators, coordinators, monitors, and other research staff. Only persons given appropriate roles on an IRB approved study have access to the study information in PowerTrials. Features of PowerTrials include:

  • Indication in the electronic health record that a patient is on an interventional study.
  • Basic study information to support patient care, especially in emergent situations.
  • Easy work flow, interaction, and research access to PowerChart.
  • A "Clinical Studies" section on the patient level in PowerChart. This section makes available a summary of the study, informed consent document(s), drug information, and clinical research notes.
  • Enables greater ease in viewing study participant health information.

PowerTrials has a component called Screener. Researchers can utilize PowerTrials Screener to obtain study feasibility information. Screener can provide the number of patients that have been seen at AUMC or the Children's Hospital of Georgia in the past 5 years that meet the major study criteria. This type of information does not require IRB approval. PowerTrials Screener can guide protocol development and enable the discovery and prioritization of research opportunities.

PowerTrials Screener also enables research staff to obtain a list of potential study subjects from the hospital electronic health record. Screener scans study inclusion and exclusion criteria from PowerChart to better define patients who may meet study eligibility requirements. In order to obtain specific patient information, PowerTrials Screener needs to be indicated as a method of study subject recruitment in the initial submission to the Institutional Review Board (IRB) or by an amendment if the study is already IRB approved. The method(s) as to how potential subjects will be contacted needs to be described (i.e. phone call, email, or letter).

PowerTrials Screener uses a HIPAA compliant process. Security is supported in PowerChart, PowerTrials, and Screener through Citrix using application logins, passwords and research access based on role.